I
ndividuals with co-occurring cocaine and opioid use disorders have more severe drug use and legal problems and poorer substance use treatment outcomes compared with individuals with either substance use disorder alone. 1, 2 Research shows that heroin use among people using cocaine increased significantly between 2008 to 2010 and 2011 to 2013 and that cocaine use disorder was a significant risk factor for both heroin and prescription opioid use disorder. 3, 4 Since 2010, overdose deaths involving heroin and, more recently, synthetic opioids (e.g., illicitly manufactured fentanyl) have increased. 5 A recent investigation of fentanyl overdose deaths in Florida and Ohio found that cocaine use was commonly involved in these deaths. 6 An examination of how the increase in opioid use among cocaine users has affected cocaine overdose deaths in the United States is lacking. We examined drug overdose death data to assess this relationship and inform public health overdose prevention and treatment strategies.
METHODS
Data were from the National Vital Statistics System multiple cause-of-death mortality files. Drug overdose deaths were those assigned an International Classification of Diseases, 10th Revision, 7 underlying cause-ofdeath code: X40-44 (unintentional), X60-64 (intentional self-harm), X85 (homicide), and Y10-Y14 (undetermined intent). Cocaine-related overdose deaths were those assigned code T40.5; overdose deaths involving natural or semisynthetic opioids were those assigned T40.2; methadone, T40.3; heroin, T40.1; and synthetic opioids (not including methadone), T40.4.
For cocaine-related overdose deaths, we calculated the rate and number of deaths by year for 2000 through 2015 overall and by deaths involving natural or semisynthetic opioids, methadone, heroin, or synthetic opioids (termed any opioid deaths); deaths involving heroin or synthetic opioids; and deaths not involving opioids. We also calculated, by year, percentages of cocaine-related overdose deaths involving any opioid and the percentages of these deaths involving heroin or synthetic opioids. Emerging research suggests that the increase in synthetic opioid-related deaths is predominantly the result of increased exposure to illicitly manufactured fentanyl, and the population of individuals using fentanyl largely resembles those using heroin in the United States. 8, 9 For these reasons, we examined deaths involving heroin or synthetic opioids as a single group. All rates were calculated per 100 000 population and were age-adjusted by applying age-specific death rates to the 2000 US standard population age distribution. Significance testing was based on the z test at a significance level of .05. We used Joinpoint Regression, version 4.2.0.2 (National Cancer Institute, Bethesda, MD), to examine changes in trends between 2000 and 2015. Joinpoint regression models annual trend data by fitting an exponential curve (i.e., no annual percentage change), then adding joinpoints, 1 at a time, and performing a Monte Carlo permutation test to determine the optimal number of joinpoints. In the final model, each joinpoint indicates a statistically significant increase or decrease in trend, and each of these trends is described by the annual percentage change between each joinpoint. A P value of less than .05 was considered statistically significant.
RESULTS
Cocaine-related overdose death rates increased significantly from 1.26 to 2.50 per 100 000 population from 2000 (n = 3544) to 2006 (n = 7448; Table 1 ). After 2006, the death rate declined to 1.35 per 100 000 (n = 4183) in 2010 before rising to 2.13 per 100 000 (n = 6784) in 2015. The rate of cocaine-related overdose death not involving opioids increased from 0.89 to 1.59 per 100 000 from 2000 (n = 2501) to 2006 (n = 4731) and then declined to 0.78 per 100 000 (n = 2513) in 2015.
Cocaine-related overdose death rates involving any opioid increased from 0.37 to 0.91 per 100 000 from 2000 (n = 1043) to 2006 (n = 2717). After 2006, the death rate declined to 0.57 per 100 000 (n = 1750) in 2010 before rising to 1.36 per 100 000 (n = 4271) in 2015. The rate of cocainerelated overdose deaths involving heroin or synthetic opioids increased from 0.20 to 0.38 per 100 000 from 2000 (n = 576) to 2006 (n = 1129) and then declined to 0.24 per 100 000 (n = 727) in 2010 before increasing to 1.11 per 100 000 (n = 3481) in 2015.
The percentage of cocaine-related overdose deaths involving any opioid increased from 29.4% in 2000 to 63.0% in 2015 (Table  A , available as a supplement to the online version of this article at http://www.ajph. org). Among these deaths, heroin or synthetic opioids have been increasingly contributing to these deaths since 2010, contributing to 81.5% of these deaths in 2015.
Joinpoint regression estimates are indicated in Table 1 Note. Rates were calculated per 100 000 population and were age-adjusted by applying age-specific death rates to the 2000 US standard population age distribution. cocaine-related overdose deaths declined. However, after 2010, despite continued declines in cocaine use, 11 overdose deaths involving cocaine increased more than 60%. This increase in deaths occurred when opioids, primarily heroin or synthetic opioids, also were involved and corresponds to the growing supply and use of heroin and illicitly manufactured fentanyl in the United States. 3, 6, 9 The public health and public safety response to increasing cocaine-related overdose deaths should be comprehensive and informed by the role opioids play. This is particularly important given the rapid increase in cocaine-related deaths involving synthetic opioids such as fentanyl and its highly potent analogs.
Use of opioids can lead to sudden respiratory depression. This is particularly true for fentanyl and its analogs because of their potency and rapid onset of action. In the absence of recent, regular opioid use, someone using cocaine and fentanyl (knowingly or unknowingly) would be highly susceptible to opioid-induced respiratory depression and subsequent overdose. Reports indicate that this is occurring. 12, 13 Having naloxone readily available-even among people primarily using cocaine-is a key strategy for reducing overdose deaths. Additionally, because fentanyl (and its analogs) may necessitate multiple doses to reverse an overdose, at-risk individuals and first responders should be equipped with adequate naloxone supplies. Expanding the provision of medicationassisted treatment with methadone, buprenorphine, or naltrexone in combination with behavioral health services is also crucial to treat co-occurring opioid and cocaine use disorders. For persons who use opioids, regardless of whether they also use cocaine, such medical treatments are essential for reducing substance use and improving health and social outcomes. In addition, the use of contingency management has been found to be particularly useful to reduce cocaine use (for additional references on these interventions, see Table B , available as a supplement to the online version of this article at http://www. ajph.org).
This study had several limitations. Throughout the study period, approximately 20% to 25% of the death certificates did not specify the type of drug(s) involved, and changes in death certificate documentation during the study period could have affected our findings. In addition, although cocaine was specified as a contributing cause of death for these analyses, it may not have been the primary drug involved.
PUBLIC HEALTH IMPLICATIONS
Differentiating cocaine-related deaths from those influenced by opioids has become increasingly difficult. Public health and public safety officials should implement broad public health prevention and treatment strategies as well as supply reduction efforts that attend to use of both drugs simultaneously. 
HUMAN PARTICIPANT PROTECTION
Human participant protection was not required because the study was a secondary analysis of de-identified data.
